Morphosys AG (MOR)

  0.00
   
  • Closing Price Chg:
     0.00
  • 52 Week High:  0.00
  • 52 Week Low:  0.00
  • Currency: Euro
  • Shares Issued: 31.84m
  • Volume: 0

Morphosys AG Overview

MorphoSys is a biotechnology company engaged in the development of fully human antibodies that can be used for research, diagnostics, and treating diseases.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.0%
Div Cover n/a
Op Mrgn -77.3%
ROCE n/a
Latest F'cast
P/E n/a
PEG n/a
Pr/Revenue n/a
Pr/Book n/a
Latest F'cast
Revenue 14.5%
PBT n/a
EPS n/a
DPS n/a

Morphosys AG Fundamentals

Year Ending Revenue ( m) Pre-tax ( m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-14 63.98 (4.31) (12.00)¢ n/a n/a n/a n/a 0.0%
31-Dec-15 106.22 20.63 57.00¢ n/a n/a n/a n/a 0.0%
31-Dec-16 49.74 (59.86) (228.00)¢ n/a n/a n/a n/a 0.0%
31-Dec-17 66.79 (68.79) (241.00)¢ n/a n/a n/a n/a 0.0%
31-Dec-18 76.44 (60.48) (179.00)¢ n/a n/a n/a n/a 0.0%

Morphosys AG Top Newspaper Links

Morphosys-Lizenzen gehen gut 28-Apr-2006 N-TV

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Forecast figures based on normalised accounts.

 

Morphosys AG Market Data

Currency Euro
Share Price   0.00
Closing Price Change   0.00
% Change 0.00 %
52 Week High  0.00
52 Week Low  0.00
Volume 0
Shares Issued 31.84m

Top of Page